株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

API (原薬) の世界市場:2019年~2026年

Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Application, By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 447118
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
API (原薬) の世界市場:2019年~2026年 Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Application, By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年03月05日 ページ情報: 英文 120 Pages
概要

世界のAPI (原薬) 市場は、2026年までに2,681億2000万米ドルに達すると見られています。市場は、2026年までのCAGR (複合年間成長率) で、6.8%の成長が予測されています。

当レポートでは、世界のAPI (原薬) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 普及率・成長見通しマッピング

第4章 市場力学

  • 市場促進要因分析
  • 市場抑制要因分析

第5章 API市場分析ツール

  • ファイブフォース分析
  • PESTEL分析
  • 主要取引・戦略的提携分析

第6章 API市場:競合分析

  • 最近の発展・影響分析:主要企業別
  • 企業/競合分類
  • 公開企業
  • 民間企業

第7章 API分子の見通し

  • 世界の売上高
  • 主要市場ポジション企業
  • 比較価格分析

第8章 合成タイプ別のビジネス分析

  • 定義・範囲
  • 合成タイプ別の市場シェア分析
  • API市場:合成タイプ別
  • 市場規模・予測・動向分析
  • バイオテクノロジーAPI
  • 合成API

第9章 メーカータイプ別のビジネス分析

  • 定義・範囲
  • メーカータイプ別の市場シェア分析
  • API市場:メーカータイプ別
  • 市場規模・予測・動向分析
  • キャプティブAPI
  • マーチャントAPI

第10章 タイプ別のビジネス分析

  • 定義・範囲
  • タイプ別の市場シェア分析
  • API市場:タイプ別
  • 市場規模・予測・動向分析
  • ジェネリックAPI
  • 革新的API

第11章 応用別のビジネス分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 心臓
  • 腫瘍
  • CNS・神経
  • 整形外科
  • 内分泌
  • 呼吸器
  • 消化器
  • 腎臓
  • 眼科
  • その他

第12章 応用タイプ別のビジネス分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 心臓
  • 腫瘍
  • CNS・神経
  • 整形外科
  • 内分泌
  • 呼吸器
  • 消化器
  • 腎臓
  • 眼科
  • その他

第13章 API市場:地域別の推計・動向分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第14章 競合情勢

  • 企業プロファイル
    • ABBVIE, INC.
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • BRISTOL-MYERS SQUIBB COMPANY
    • CIPLA INC.
    • MERCK & CO., INC.
    • ALBEMARLE CORPORATION
    • AUROBINDO PHARMA
    • MYLAN N.V.
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • SUN PHARMACEUTICAL INDUSTRIES, LTD.
    • DR. REDDY'S LABORATORIES LTD.
図表

List of Tables

  • TABLE 1 List of abbreviation
  • TABLE 2 North America API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 3 North America biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 4 North America API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 5 North America merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 6 North America API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 7 North America API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 8 North America cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 9 North America oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 10 North America CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 11 North America orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 12 North America endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 13 North America pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 14 North America gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 15 North America nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 16 North America ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 17 North America others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 18 U.S. API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 19 U.S. biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 20 U.S. API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 21 U.S. merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 22 U.S. API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 23 U.S. API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 24 U.S. cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 25 U.S. oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 26 U.S. CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 27 U.S. orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 28 U.S. endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 29 U.S. pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 30 U.S. gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 31 U.S. nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 32 U.S. ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 33 U.S. others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 34 Canada API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 35 Canada biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 36 Canada API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 37 Canada merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 38 Canada API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 39 Canada API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 40 Canada cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 41 Canada oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 42 Canada CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 43 Canada orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 44 Canada endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 45 Canada pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 46 Canada gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 47 Canada nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 48 Canada ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 49 Canada others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 50 Europe API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 51 Europe biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 52 Europe API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 53 Europe merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 54 Europe API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 55 Europe API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 56 Europe cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 57 Europe oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 58 Europe CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 59 Europe orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 60 Europe endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 61 Europe pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 62 Europe gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 63 Europe nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 64 Europe ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 65 Europe others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 66 Germany API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 67 Germany biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 68 Germany API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 69 Germany merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 70 Germany API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 71 Germany API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 72 Germany cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 73 Germany oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 74 Germany CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 75 Germany orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 76 Germany endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 77 Germany pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 78 Germany gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 79 Germany nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 80 Germany ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 81 Germany others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 82 U.K. API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 83 U.K. biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 84 U.K. API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 85 U.K. merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 86 U.K. API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 87 U.K. API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 88 U.K. cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 89 U.K. oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 90 U.K. CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 91 U.K. orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 92 U.K. endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 93 U.K. pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 94 U.K. gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 95 U.K. nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 96 U.K. ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 97 U.K. others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 98 France API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 99 France biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 100 France API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 101 France merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 102 France API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 103 France API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 104 France cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 105 France oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 106 France CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 107 France orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 108 France endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 109 France pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 110 France gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 111 France nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 112 France ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 113 France others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 114 Italy API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 115 Italy biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 116 Italy API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 117 Italy merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 118 Italy API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 119 Italy API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 120 Italy cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 121 Italy oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 122 Italy CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 123 Italy orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 124 Italy endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 125 Italy pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 126 Italy gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 127 Italy nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 128 Italy ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 129 Italy others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 130 Spain API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 131 Spain biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 132 Spain API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 133 Spain merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 134 Spain API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 135 Spain API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 136 Spain cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 137 Spain oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 138 Spain CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 139 Spain orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 140 Spain endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 141 Spain pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 142 Spain gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 143 Spain nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 144 Spain ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 145 Spain others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 146 Russia API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 147 Russia biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 148 Russia API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 149 Russia merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 150 Russia API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 151 Russia API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 152 Russia cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 153 Russia oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 154 Russia CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 155 Russia orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 156 Russia endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 157 Russia pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 158 Russia gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 159 Russia nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 160 Russia ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 161 Russia others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 162 Asia Pacific API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 163 Asia Pacific biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 164 Asia Pacific API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 165 Asia Pacific merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 166 Asia Pacific API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 167 Asia Pacific API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 168 Asia Pacific cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 169 Asia Pacific oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 170 Asia Pacific CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 171 Asia Pacific orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 172 Asia Pacific endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 173 Asia Pacific pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 174 Asia Pacific gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 175 Asia Pacific nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 176 Asia Pacific ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 177 Asia Pacific others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 178 Japan API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 179 Japan biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 180 Japan API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 181 Japan merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 182 Japan API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 183 Japan API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 184 Japan cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 185 Japan oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 186 Japan CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 187 Japan orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 188 Japan endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 189 Japan pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 190 Japan gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 191 Japan nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 192 Japan ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 193 Japan others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 194 China API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 195 China biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 196 China API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 197 China merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 198 China API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 199 China API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 200 China cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 201 China oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 202 China CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 203 China orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 204 China endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 205 China pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 206 China gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 207 China nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 208 China ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 209 China others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 210 India API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 211 India biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 212 India API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 213 India merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 214 India API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 215 India API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 216 India cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 217 India oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 218 India CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 219 India orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 220 India endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 221 India pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 222 India gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 223 India nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 224 India ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 225 India others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 226 South Korea API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 227 South Korea biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 228 South Korea API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 229 South Korea merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 230 South Korea API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 231 South Korea API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 232 South Korea cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 233 South Korea oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 224 South Korea CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 225 South Korea orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 226 South Korea endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 227 South Korea pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 228 South Korea gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 229 South Korea nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 230 South Korea ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 231 South Korea others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 232 Australia API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 233 Australia biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 234 Australia API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)
  • TABLE 235 Australia merchant API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 236 Australia API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 237 Australia API market estimates and forecasts, by application, 2014 - 2026 (USD Billion)
  • TABLE 238 Australia cardiology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 239 Australia oncology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 240 Australia CNS and neurology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 241 Australia orthopedic API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 242 Australia endocrinology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 243 Australia pulmonology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 244 Australia gastroenterology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 245 Australia nephrology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 246 Australia ophthalmology API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 247 Australia others market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 248 Latin America API market estimates and forecasts, by type of synthesis, 2014 - 2026 (USD Billion)
  • TABLE 249 Latin America biotech API market estimates and forecasts, by type, 2014 - 2026 (USD Billion)
  • TABLE 250 Latin America API market estimates and forecasts, by type of manufacturer, 2014 - 2026 (USD Billion)

List of Figures

  • Fig.1 API Market Segmentation
  • Fig.2 Information Procurement
  • Fig.3 QFD modelling for market share assessment
  • Fig.4 API Market, 2018
  • Fig.5 Penetration and growth prospect mapping
  • Fig.6 API Market Driver Impact
  • Fig.7 Global percentage of population, by age group, 2050 and 2000
  • Fig.8 API Market Restraint Impact
  • Fig.9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig.10 Porter's Five Forces Analysis
  • Fig.11 API market: Type of synthesis outlook and key takeaways
  • Fig.12 API Market: Type Movement Analysis
  • Fig.13 Biotech API market estimates and forecast, 2014 - 2026
  • Fig.14 Monoclonal antibodies market estimates and forecast, 2014 - 2026
  • Fig.15 Recombinant proteins market estimates and forecast, 2014 - 2026
  • Fig.16 Vaccines market estimates and forecast, 2014 - 2026
  • Fig.17 Synthetic API market estimates and forecast, 2014 - 2026
  • Fig.18 API market: Type of manufacturer outlook and key takeaways
  • Fig.19 API Market: Type Movement Analysis
  • Fig.20 Captive API market estimates and forecast, 2014 - 2026
  • Fig.21 Merchant API market estimates and forecast, 2014 - 2026
  • Fig.22 API market: Type outlook and key takeaways
  • Fig.23 API Market: Type Movement Analysis
  • Fig.24 Generic APIs market estimates and forecast, 2014 - 2026
  • Fig.25 Innovative APIs market estimates and forecast, 2014 - 2026
  • Fig.26 API market: Application outlook and key takeaways
  • Fig.27 API Market: Application Movement Analysis
  • Fig.28 Cardiology market estimates and forecast, 2014 - 2026
  • Fig.29 Oncology market estimates and forecast, 2014 - 2026
  • Fig.30 CNS & neurology market estimates and forecast, 2014 - 2026
  • Fig.31 Orthopedics market estimates and forecast, 2014 - 2026
  • Fig.32 Endocrinology market estimates and forecast, 2014 - 2026
  • Fig.33 Pulmonology market estimates and forecast, 2014 - 2026
  • Fig.34 Gastrointestinal disorders market estimates and forecast, 2014 - 2026
  • Fig.35 Nephrology market estimates and forecast, 2014 - 2026
  • Fig.36 Ophthalmology market estimates and forecast, 2014 - 2026
  • Fig.37 Others market estimates and forecast, 2014 - 2026
  • Fig.38 API market: Regional movement analysis
  • Fig.39 North America
  • Fig.40 North America market estimates and forecast, 2014 - 2026
  • Fig.41 U.S. market estimates and forecast, 2014 - 2026
  • Fig.42 Canada market estimates and forecast, 2014 - 2026
  • Fig.43 Europe
  • Fig.44 Europe market estimates and forecast, 2014 - 2026
  • Fig.45 Germany market estimates and forecast, 2014 - 2026
  • Fig.46 U.K. market estimates and forecast, 2014 - 2026
  • Fig.47 Spain market estimates and forecast, 2014 - 2026
  • Fig.48 France market estimates and forecast, 2014 - 2026
  • Fig.49 Italy market estimates and forecast, 2014 - 2026
  • Fig.50 Russia market estimates and forecast, 2014 - 2026
  • Fig.51 Asia Pacific
  • Fig.52 Asia-Pacific market estimates and forecast, 2014 - 2026
  • Fig.53 Japan market estimates and forecast, 2014 - 2026
  • Fig.54 China. market estimates and forecast, 2014 - 2026
  • Fig.55 India market estimates and forecast, 2014 - 2026
  • Fig.56 South Korea market estimates and forecast, 2014 - 2026
  • Fig.57 Australia market estimates and forecast, 2014 - 2026
  • Fig.58 Latin America
  • Fig.59 Latin America market estimates and forecast, 2014 - 2026
  • Fig.60 Brazil market estimates and forecast, 2014 - 2026
  • Fig.61 Mexico market estimates and forecast, 2014 - 2026
  • Fig.62 Argentina market estimates and forecast, 2014 - 2026
  • Fig.63 Middle East & Africa
  • Fig.64 MEA market estimates and forecast, 2014 - 2026
  • Fig.65 South Africa market estimates and forecast, 2014 - 2026
  • Fig.66 Saudi Arabiamarket estimates and forecast, 2014 - 2026
  • Fig.67 UAE market estimates and forecast, 2014 - 2026
  • Fig.68 Strategic framework
目次
Product Code: GVR-1-68038-348-5

The global active pharmaceutical ingredient (API) market size is expected to reach at USD 268.12 billion by 2026 registering a CAGR of 6.8%, according to a new report by Grand View Research, Inc. Rising trend of outsourcing APIs and growing prevalence of various target diseases, such as cancer, Cardiovascular Disease (CVDs) are anticipated to boost the market. Huge capital is required in API production as the process needs extremely systematic protocols. Pharmaceutical companies can actually benefit from outsourcing API production, as it eliminates the need for installing expensive manufacturing units. Moreover, strategic outsourcing enables companies to focus on their core competencies, ultimately resulting in increased productivity. These factors are also estimated to drive the demand in future.

Growing geriatric population across the globe is also likely to contribute to the market expansion. Estimates published by the WHO suggest that the global base of population pertaining to the age group of 65 years and above is expected to rise from 7% in 2000 to 16% in 2050. Latin America, in particular, is projected to witness fastest growth, in terms of geriatric population, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%). Patent expiration of blockbuster drugs, growing outsourcing activities due to high manufacturing costs, and stringent regulations for API production are expected to intensify the market competition. As part of strategic geographic expansion, many companies are setting up manufacturing plants in the developing regions like Asia Pacific.

Further key findings from the study suggest:

  • Synthetic APIs held the largest share of the API market in 2018 owing to easy availability of raw materials and easier protocols for synthesis of these molecules
  • Biotech APIs are estimated to register the highest CAGR over the forecast years due to rising demand for biopharmaceuticals and higher efficiency of these molecules
  • Captive manufacturers led the market owing to intensive capitalization of major key players in development of high-end manufacturing facilities
  • Merchant manufacturers segment is expected to be the fastest-growing segment over the forecast period
  • Generic APIs are expected to register a lucrative CAGR over the forecast period on account of factors, such as expiration of patents of branded drugs and lower cost
  • Cardiology segment led the overall market in 2018. Increasing prevalence of target diseases worldwide and high demand for fast-acting drugs are some of the key factors responsible for the segment growth
  • North America held the largest market share in 2018. Asia Pacific is estimated to be the fastest-growing region expanding at a CAGR of 8.2% over the estimated period

Some of the major companies in the market are: Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Boehringer Ingelheim International GmbH; Cipla Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; Albemarle Corporation; Mylan N.V.; Aurobindo Pharma; Sun Pharmaceutical Industries Ltd.; and Dr. Reddy's Laboratories Ltd.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Validation & Publishing
  • 1.7 Geographic Scope & Assumptions
  • 1.8 Region-Wise Market Calculation
    • 1.8.1 Region-Wise Market: Base Estimates
  • 1.9 Market CAGR Calculation
    • 1.9.1 Region Based Segment Share Calculation

Chapter 2 Executive Summary

  • 2.1 API Market Outlook
  • 2.2 API Market: - Segment Outlook
  • 2.3 API Market: -Competitive Insights
  • 2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping

Chapter 4 Market Dynamics

  • 4.1 Market Driver Analysis
    • 4.1.1 Growing Geriatric Population Base
    • 4.1.2 Growing Prevalence Of Target Diseases Such As Hospital Acquired Infections, Genetic, Cardiovascular And Neurological Diseases
    • 4.1.3 Increasing Preference For Targeted Therapy Approach In Cancer Treatment
    • 4.1.4 Increasing Preference For Outsourcing APIs
  • 4.2 Market Restraint Analysis
    • 4.2.1 Large Capital Investments And Production Cost
    • 4.2.2 Stringent Safety And Handling Regulations Regarding APIs

Chapter 5 API Market Analysis Tools

  • 5.1 Industry Analysis - Porter's
    • 5.1.1 Supplier Power: Moderate Due To Large Number Of Diagnostic Test Manufacturers
    • 5.1.2 Buyer Power: Moderate Due To Presence Of Players Entering Into Long-Term Contract
    • 5.1.3 Substitution Threat: Low Due To No/ Less External Substitutes
    • 5.1.4 Threat From New Entrant: Moderate Due To Brand Recognition Of The Existing Players
    • 5.1.5 Competitive Rivalry: High Due To Increasing Mergers & Acquisitions By Major Players
  • 5.2 PESTEL Analysis
    • 5.2.1 Political Landscape
    • 5.2.2 Environmental Landscape
    • 5.2.3 Social Landscape
    • 5.2.4 Technology Landscape
    • 5.2.5 Legal Landscape
  • 5.3 Major Deals & Strategic Alliances Analysis
    • 5.3.1 Joint Ventures
    • 5.3.2 Mergers & Acquisitions
    • 5.3.3 Licensing & Partnership
    • 5.3.4 Technology Collaborations
    • 5.3.5 Strategic Divestments

Chapter 6 API Market - Competitive Analysis

  • 6.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3 Public Companies
    • 6.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
    • 6.3.2 Company Market Share/Ranking, By Region
    • 6.3.3 Competitive Dashboard Analysis
    • 6.3.4 Market Differentiators
    • 6.3.5 Synergy Analysis: Major Deals & Strategic Alliances
  • 6.4 Private Companies
    • 6.4.1 List Of Key Emerging Companies
    • 6.4.2 Regional Network Map
    • 6.4.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)

Chapter 7 API Molecules Outlook

  • 7.1 Global Sales (2014 - 2017)
  • 7.2 Companies With Leading Market Position For API Molecules
    • 7.2.1 Amoxicillin
    • 7.2.2 Azithromycin
    • 7.2.3 Bleomycin
    • 7.2.4 Caspofungin
    • 7.2.5 Clarithromycin
    • 7.2.6 Clavulanic Acid
    • 7.2.7 Clindamycin
    • 7.2.8 Compactin (Mevastatin)
    • 7.2.9 Cyclosporin
    • 7.2.10 Dactinomycin
    • 7.2.11 Daptomycin
    • 7.2.12 Demeclocycline
    • 7.2.13 Doxycycline
    • 7.2.14 Erythromycin
    • 7.2.15 Ivermectin (Avermectin)
    • 7.2.16 Lovastatin
    • 7.2.17 Micafungin
    • 7.2.18 Minocycline
    • 7.2.19 Mitomycin
    • 7.2.20 Mycophenolic Acid
    • 7.2.21 Pneumocandin B0
    • 7.2.22 Polymyxin
    • 7.2.23 Pravastatin
    • 7.2.24 Rapamycin (Sirolimus)
    • 7.2.25 Simvastatin
    • 7.2.26 Steroids
    • 7.2.27 Tacrolimus
    • 7.2.28 Tetracycline
    • 7.2.29 Tigecycline
    • 7.2.30 Tobramycin
    • 7.2.31 Vancomycin
  • 7.3 Comparative Price Analysis Of The Above-Mentioned Molecules

Chapter 8 Type Of Synthesis Business Analysis

  • 8.1. Definitions & Scope
  • 8.2. Type of Synthesis Market Share Analysis, 2018 & 2026
  • 8.3. API Market, by Type of Synthesis, 2014 to 2026
  • 8.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 8.5 Biotech API
    • 8.5.1 Biotech API Market, 2014 - 2026 (USD Billion)
    • 8.5.2 Monoclonal Antibodies
      • 8.5.2.1 Monoclonal Antibodies Market, 2014 - 2026 (USD Billion)
    • 8.5.3 Recombinant Proteins
      • 8.5.3.1 Recombinant Proteins Market, 2014 - 2026 (USD Billion)
    • 8.5.4 Vaccines
      • 8.5.4.1 Vaccines Market, 2014 - 2026 (USD Billion)
  • 8.6 Synthetic API
    • 8.6.1 Synthetic API Market, 2014 - 2026 (USD Billion)

Chapter 9 Type Of Manufacturer Business Analysis

  • 9.1. Definitions & Scope
  • 9.2. Type of Manufacturer Market Share Analysis, 2018 & 2026
  • 9.3. API Market, by Type of Manufacturer, 2014 to 2026
  • 9.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 9.5 Captive API
    • 9.5.1 Captive API Market, 2014 - 2026 (USD Billion)
  • 9.6 Merchant API
    • 9.6.1 Merchant API Market, 2014 - 2026 (USD Billion)

Chapter 10 Type Business Analysis

  • 10.1. Definitions & Scope
  • 10.2. Type Market Share Analysis, 2018 & 2026
  • 10.3. API Market, by Type, 2014 to 2026
  • 10.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 10.5 Generic APIs
    • 10.5.1 Generic API Market, 2014 - 2026 (USD Billion)
  • 10.6 Innovative APIs
    • 10.6.1 Innovative API Market, 2014 - 2026 (USD Billion)

Chapter 11 Application Business Analysis

  • 11.1. Definitions & Scope
  • 11.2. Application Market Share Analysis, 2018 & 2026
  • 11.3. API Market, by Application, 2014 to 2026
  • 11.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 11.5 Cardiology
    • 11.5.1 Cardiology Market, 2014 - 2026 (USD Billion)
  • 11.6 Oncology
    • 11.6.1 Oncology Market, 2014 - 2026 (USD Billion)
  • 11.7 Cns & Neurology
    • 11.7.1 Cns & Neurology Market, 2014 - 2026 (USD Billion)
  • 11.8 Orthopedics
    • 11.8.1 Orthopedics Market, 2014 - 2026 (USD Billion)
  • 11.9 Endocrinology
    • 11.9.1 Endocrionology Market, 2014 - 2026 (USD Billion)
  • 11.10 Pulmonology
    • 11.10.1 Pulmonology Market, 2014 - 2026 (USD Billion)
  • 11.11 Gastroenterology
    • 11.11.1 Gastrointestinal Disorders Market, 2014 - 2026 (USD Billion)
  • 11.12 Nephrology
    • 11.12.1 Nephrology Market, 2014 - 2026 (USD Billion)
  • 11.13 Ophthalmology
    • 11.13.1 Opthalmology Market, 2014 - 2026 (USD Billion)
  • 11.14 Others
    • 11.14.1 Others Market, 2014 - 2026 (USD Billion)

Chapter 12 Application, By Type Business Analysis (Cross-Matrix)

  • 12.1. Definitions & Scope
  • 12.2. Application Market Share Analysis, 2018 & 2026
  • 12.3. API Market, by Application, 2014 to 2026
  • 12.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 12.5 Cardiology
    • 12.5.1 Generic
      • 12.5.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.5.2 Innovative
      • 12.5.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.6 Oncology
    • 12.6.1 Generic
      • 12.6.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.6.2 Innovative
      • 12.6.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.7 CNS & Neurology
    • 12.7.1 Generic
      • 12.7.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.7.2 Innovative
      • 12.7.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.8 Orthopedics
    • 12.8.1 Generic
      • 12.8.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.8.2 Innovative
      • 12.8.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.9 Endocrinology
    • 12.9.1 Generic
      • 12.9.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.9.2 Innovative
      • 12.9.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.10 Pulmonology
    • 12.10.1 Generic
      • 12.10.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.10.2 Innovative
      • 12.10.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.11 Gastroenterology
    • 12.12.1 Generic
      • 12.12.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.12.2 Innovative
      • 12.12.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.12 Nephrology
    • 12.12.1 Generic
      • 12.12.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.12.2 Innovative
      • 12.12.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.13 Ophthalmology
    • 12.13.1 Generic
      • 12.13.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.13.2 Innovative
      • 12.13.2.1 Innovative Market, 2014 - 2026 (USD Billion)
  • 12.14 Others
    • 12.14.1 Generic
      • 12.14.1.1 Generic Market, 2014 - 2026 (USD Billion)
    • 12.14.2 Innovative
      • 12.14.2.1 Innovative Market, 2014 - 2026 (USD Billion)

Chapter 13 API Market: Regional Estimates & Trend Analysis

  • 13.1. Definitions & Scope
  • 13.2. Application Market Share Analysis, 2018 & 2026
  • 13.3. API Market, by Application, 2014 to 2026
  • 13.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 13.5 North America.
    • 13.5.1 north america market estimates and forecast, 2014 - 2026
    • 13.5.2 U.S.
      • 13.5.2.1 U.S. market estimates and forecast, 2014 - 2026
    • 13.5.3 Canada
      • 13.5.3.1 Canada market estimates and forecast, 2014 - 2026
  • 13.6 Europe
    • 13.6.1 Europe market estimates and forecast, 2014 - 2026
    • 13.6.2 Germany
      • 13.6.2.1 Germany market estimates and forecast, 2014 - 2026
    • 13.6.3 U.K.
      • 13.6.3.1 U.K. market estimates and forecast, 2014 - 2026
    • 13.6.4 Spain
      • 13.6.4.1 Spain market estimates and forecast, 2014 - 2026
    • 13.6.5 France
      • 13.6.5.1 France market estimates and forecast, 2014 - 2026
    • 13.6.6 Italy
      • 13.6.6.1 Italy market estimates and forecast, 2014 - 2026
  • 13.7 Asia-Pacific
    • 13.7.1 Asia-Pacific market estimates and forecast, 2014 - 2026
    • 13.7.2 Japan
      • 13.7.2.1 Japan market estimates and forecast, 2014 - 2026
    • 13.7.3 China
      • 13.7.3.1 China market estimates and forecast, 2014 - 2026
    • 13.7.4 India
      • 13.7.4.1 India market estimates and forecast, 2014 - 2026
    • 13.7.5 South Korea
      • 13.7.5.1 South Korea market estimates and forecast, 2014 - 2026
    • 13.7.6 Australia
      • 13.7.6.1 Australia market estimates and forecast, 2014 - 2026
  • 13.8 Latin America
    • 13.8.1 Latin America market estimates and forecast, 2014 - 2026
    • 13.8.2 Brazil
      • 13.8.2.1 Brazil market estimates and forecast, 2014 - 2026
    • 13.8.3 Mexico
      • 13.8.3.1 Mexico Market estimates and forecast, 2014 - 2026
    • 13.8.4 Argentina
      • 13.8.4.1 Argentina Market estimates and forecast, 2014 - 2026
  • 13.9 Middle East and Africa
    • 13.9.1 Middle-East and Africa market estimates and forecast, 2014 - 2026
    • 13.9.2 South Africa
      • 13.9.2.1 South Africa market estimates and forecast, 2014 - 2026
      • 13.10.SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 13.10.1. North America
    • 13.10.2. Europe
    • 13.10.3. Asia Pacific
    • 13.10.4. Latin America
    • 13.10.5. Middle East & Africa

Chapter 14 Competitive Landscape

  • 14.1 Company Profiles
    • 14.1.1 ABBVIE, INC.
      • 14.1.1.1 Company overview
      • 14.1.1.2 Financial performance
      • 14.1.1.3 Product benchmarking
      • 14.1.1.4 Strategic initiatives
    • 14.1.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 14.1.2.1 Company overview
      • 14.1.2.2 Financial performance
      • 14.1.2.3 Product benchmarking
      • 14.1.2.4 Strategic initiatives
    • 14.1.3 BRISTOL-MYERS SQUIBB COMPANY
      • 14.1.3.1 Company overview
      • 14.1.3.2 Financial performance
      • 14.1.3.3 Product benchmarking
      • 14.1.3.4 Strategic initiatives
    • 14.1.4 CIPLA INC.
      • 14.1.4.1 Company overview
      • 14.1.4.2 Financial performance
      • 14.1.4.3 Product benchmarking
      • 14.1.4.4 Strategic initiatives
    • 14.1.5 MERCK & CO., INC.
      • 14.1.5.1 Company overview
      • 14.1.5.2 Financial performance
      • 14.1.5.3 Product benchmarking
      • 14.1.5.4 Strategic initiatives
    • 14.1.6 ALBEMARLE CORPORATION
      • 14.1.6.1 Company overview
      • 14.1.6.2 Financial overview
      • 14.1.6.3 Product benchmarking
      • 14.1.6.4 Strategic initiatives
    • 14.1.7 AUROBINDO PHARMA
      • 14.1.7.1 Company overview
      • 14.1.7.2 Financial overview
      • 14.1.7.3 Product benchmarking
      • 14.1.7.4 Strategic initiatives
    • 14.1.8 MYLAN N.V.
      • 14.1.8.1 Company overview
      • 14.1.8.2 Financial overview
      • 14.1.8.3 Product benchmarking
      • 14.1.8.4 Strategic initiatives
    • 14.1.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 14.1.9.1 Company overview
      • 14.1.9.2 Financial overview
      • 14.1.9.3 Product benchmarking
      • 14.1.9.4 Strategic initiatives
    • 14.1.10 SUN PHARMACEUTICAL INDUSTRIES, LTD.
      • 14.1.10.1 Company overview
      • 14.1.10.2 Financial overview
      • 14.1.10.3 Product benchmarking
      • 14.1.10.4 Strategic initiatives
    • 14.1.11 DR. REDDY'S LABORATORIES LTD.
      • 14.1.11.1 Company overview
      • 14.1.11.2 Financial overview
      • 14.1.11.3 Product benchmarking
      • 14.1.11.4 Strategic initiative
Back to Top